XML 114 R73.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses (Tables) (Brooklyn ImmunoTherapeutics, LLC)
 9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Brooklyn Immunotherapeutics, LLC [Member]    
Schedule of Accrued Expenses

Accrued expenses consist of the following:

 

    September 30,     December 31,  
    2020     2019  
Compensation payable   $ 218,764     $ 540,513  
Accrued general and administrative expenses     182,625       94,265  
Accrued research and development expenses     149,258       695,551  
Accrued interest     135,140       90,512  
Loss on legal settlement     -       100,000  
Total accrued expenses   $ 685,787     $ 1,520,841  

Accrued expenses consist of the following:

 

    December 31,  
    2019     2018  
Compensation payable   $ 540,513     $ 214,327  
Deferred rent payable     -       6,169  
Accrued general and administrative expenses     94,265       62,743  
Accrued research and development expenses     695,551       1,380,440  
Accrued interest     90,512       33,114  
Loss on legal settlement     100,000       -  
Total accrued expenses   $ 1,520,841     $ 1,696,793